Jazz Pharmaceuticals Eulerpool Ziņas

Jazz Pharmaceuticals Eulerpool News

Jazz Pharmaceuticals Akciju Ziņas

Jazz Pharmaceuticals tiek uzmanīgi vēroti no žurnālistu un investoru puses visā pasaulē. Jaunākās Jazz Pharmaceuticals ziņas mēs apkopojam šeit.

• 4. oktobris ·

  Benzinga
  Assessing Jazz Pharmaceuticals: Insights From 12 Financial Analysts
• 4. oktobris ·

  GuruFocus
  Jazz Pharmaceuticals: Unveiling Growth Potential From Non-Small Cell Lung Cancer Market
• 27. septembris ·

  SeekingAlpha
  Zymeworks Approaching A Moment Of Truth With Zanidatamab
• 19. septembris ·

  SeekingAlpha
  Jazz Pharmaceuticals: Zanidatamab Is A Potential Growth Catalyst
• 18. septembris ·

  Yahoo
  Jazz Pharmaceuticals' (NASDAQ:JAZZ) earnings have declined over five years, contributing to shareholders 16% loss
• 18. septembris ·

  TipRanks
  Jazz Pharmaceuticals (JAZZ) Gets a Buy from Truist Financial
• 16. septembris ·

  Yahoo
  Jazz Pharmaceuticals Presents Updated Phase 2 Data for Zanidatamab Demonstrating Increased mPFS in HER2-Positive Metastatic Gastroesophageal Adenocarcinoma at ESMO 2024
• 16. septembris ·

  Thefly.com
  Jazz Pharmaceuticals presents updated Phase 2 data for zanidatamab
• 15. septembris ·

  Seeking Alpha
  Stock moves reflect downgrade for US economic growth outlook - Goldman
• 12. septembris ·

  Thefly.com
  Truist healthcare analyst holds an analyst/industry conference call